tiprankstipranks

James Healy Insider Profile

18 Followers
James Healy, Director at Amarin, holds 1.60M shares in Natera (Ticker: NTRA), holds 2.00M shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 2.23M shares in Y-Mabs Therapeutics (Ticker: YMAB).
tipranks
James Healy

James Healy
Amarin (AMRN)
Director

Ranked #4,079 out of 99,335 Corporate Insiders

Profitable Transactions

67%
14 out of 21 Profitable Transactions

Average Return

+20.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$391M
68.26%
11.91%
11.78%
5.92%
2.13% Others
A breakdown of James Healy's holdings

Insider Roles

Natera
(NTRA)
Director
ArriVent BioPharma, Inc.
(AVBP)
Director
Rapport Therapeutics, Inc.
(RAPP)
Director
Y-Mabs Therapeutics
(YMAB)
Director
+6 other positions
Roles that James Healy holds in companies

Most Profitable Insider Trade

Stock:
Karuna Therapeutics
(KRTX)
Rating:Informative Buy
Date:Jul 02, 2019 - Jul 02, 2020
Return:+405.70%
The most profitable trade made by James Healy

James Healy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amarin
Sep 05, 2012
Director
Informative Buy
30.90K
$3.51M
Natera
Oct 29, 2024
Director
Uninformative Buy
$266.99M
PDS Biotechnology
Director
Coherus Biosciences
Sep 29, 2021
Director
Informative Sell
7.25M
$76.39K
Y-Mabs Therapeutics
Jun 13, 2024
Director
Uninformative Buy
$23.17M
Iterum Therapeutics
May 29, 2019
Director, Ten Percent Owner
Uninformative Buy
38.52K
$3.14M
KRTX
Karuna Therapeutics
Mar 18, 2024
Uninformative Sell
466.83M
$0.00
Bolt Biotherapeutics
Feb 09, 2021
Director
Uninformative Buy
$1.59M
CINC
Cincor Pharma
Feb 27, 2023
Uninformative Sell
$0.00
ArriVent BioPharma, Inc.
Jan 31, 2024
Director
Uninformative Buy
$46.58M
Rapport Therapeutics, Inc.
Jul 03, 2024
Director
Informative Buy
1.08M
$46.08M
HPTX
Hyperion Therapeutics
May 08, 2015
Uninformative Sell
89.57M
HGENQ
Humanigen
Feb 07, 2013
Uninformative Buy
$4.56K
Anthera Pharmaceuticals
Jan 31, 2012
Director
Informative Sell
50.28K
$973.29
ITMN
InterMune
Jun 03, 2014
Uninformative Buy
PRTK
Paratek Pharmaceuticals
$5.12M
DRTX
Durata
Jul 25, 2012
Uninformative Buy
List of latest transactions for each holding click on a transaction to see James Healy's performance on stock

James Healy insider profile FAQ

What is the percentage of profitable transactions made by James Healy?
The percentage of profitable transactions made by James Healy is 67%.
    What is the average return per transaction made by James Healy?
    The average return per transaction made by James Healy is 20.20%.
      What stocks does James Healy hold?
      James Healy holds: AMRN, NTRA, PDSB, CHRS, YMAB, ITRM, KRTX, BOLT, CINC, AVBP, RAPP, HPTX, HGENQ, ANTH, ITMN, PRTK, DRTX stocks.
        What was James Healy’s latest transaction?
        James Healy latest transaction was an Uninformative Buy of ―.
          What was James Healy's most profitable transaction?
          James Healy’s most profitable transaction was an Informative Buy of KRTX stock on July 2, 2019. The return on the trade was 405.70%.
            What is James Healy's role in Amarin?
            James Healy's role in Amarin is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.